AHF Slams Express Scripts Over Lawsuit to Retract Critical PBM Report

AIDS Healthcare Foundation (AHF) joins the many healthcare providers outraged over Express Scripts’ meritless lawsuit designed to deflect attention away from PBM abuses that harm patient care. It is laughable that ESI would demand a retraction of an agency report released by the Federal Trade Commission (FTC) that highlights the role pharmacy benefit managers (PBMs) play in the high cost of prescription drugs.

The lawsuit comes as the FTC readies litigation against the three largest PBMs for a host of anticompetitive practices that distort the prescription drug market in favor of drug middlemen at the expense of independent pharmacies and the everyday Americans they serve. The timing is anything but a coincidence.

The three largest PBMs – Express Scripts, CVS Caremark, and OptumRx – control approximately 80% of the prescription drug market. With such power, PBMs exploit their privileged position in the prescription drug supply chain, demanding higher rebates from pharmaceutical companies in exchange for access to formularies – the lists PBMs develop for insurers to administer prescription drug plans.

AHF knows all too well how the big three PBM/health insurance mega firms treat independent pharmacies. By design, PBMs force AHF patients out of our custom HIV-care model and into mandatory mail-order delivery, undermining health outcomes. Express Scripts and the other PBM conglomerates provide no value to our patients but want to dictate how people living with HIV access care and therapeutics.

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.1 million individuals across 47 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240917647635/en/